Atsushi Tajima

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Glycemic Control

Cardiovascular Disease

Combination Therapy

Top Venues

BMJ open diabetes research & care

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Atsushi Tajima, Keisuke Tobe, Jun-Ichi Eiki, Hideki Origasa, Hirotaka Watada, Iichiro Shimomura, Shigeru Tokita, Takashi Kadowaki
Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND). BMJ open diabetes research & care 10 (6) (2023)
Atsushi Tajima, Machiko Abe, Jessica Weaver, Min Huang
Cost-effectiveness analysis of pediatric immunization program with 15-valent pneumococcal conjugate vaccine in Japan. Journal of medical economics (2023)
Atsushi Tajima, Keisuke Tobe, Jun-Ichi Eiki, Hideki Origasa, Hirotaka Watada, Iichiro Shimomura, Shigeru Tokita, Takashi Kadowaki
Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND). BMJ open diabetes research & care 10 (6) (2023)
Atsushi Tajima, Keisuke Tobe, Jun-Ichi Eiki, Hideki Origasa, Hirotaka Watada, Iichiro Shimomura, Shigeru Tokita, Takashi Kadowaki
Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND). BMJ open diabetes research & care 10 (6) (2023)
Atsushi Tajima, Keisuke Tobe, Jun-Ichi Eiki, Hideki Origasa, Hirotaka Watada, Iichiro Shimomura, Shigeru Tokita, Takashi Kadowaki
Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND). BMJ open diabetes research & care 10 (6) (2023)
Atsushi Tajima, Keisuke Tobe, Jun-Ichi Eiki, Hideki Origasa, Hirotaka Watada, Iichiro Shimomura, Shigeru Tokita, Takashi Kadowaki
Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND). BMJ open diabetes research & care 10 (6) (2023)